ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1007

Vascular Deposition of Oxidized LDL Is Increased in Children with Untreated Juvenile Dermatomyositis

Jacob Spitznagle1, Akadia Kacha-Ochana2, Joan Cook-Mills3, Amer Khojah2, Gabrielle Morgan4 and Lauren Pachman5, 1Hospital for Special Surgery, New York, NY, 2Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 3Indiana University School of Medicine, Departments of Pediatrics and Microbiology & Immunology, Indianapolis, IN, 4Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern University Feinberg School of Medicine, Chicago, IL, 5Northwestern's Feinberg School of Medicine. Ann and Robert H. Lurie Children's Hospital of Chicago; Stanley Manne Children's Research Institute of Chicago, Lake Forest, IL

Meeting: ACR Convergence 2021

Keywords: Cardiovascular, dermatomyositis, Myositis, Pediatric rheumatology, Subclinical Cardiovascular Disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Pediatric Rheumatology – Basic Science Poster (1007–1013)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Juvenile dermatomyositis (JDM) is a systemic vasculopathy associated with metabolic derangements and possible increased risk for premature atherosclerosis. Oxidation of low-density lipoprotein (LDL) in the endothelial wall of blood vessels is an early step in atherosclerotic plaque formation. The primary aim of this study was to compare deposition of oxidized LDL in the vasculature of muscle biopsies (MBx) from patients with untreated JDM compared to pediatric controls.

Methods: After informed consent, MRI-directed MBx were obtained from 20 female patients with JDM (mean age = 6.3+/-2.2) before the start of therapy and 5 female controls (mean age = 14.4+/-1.8). Frozen muscle sections were stained with DAPI and fluorescently labeled antibodies against von Willebrand factor (vWF) and LDL oxidized by copper (oxLDL) and were imaged by a Leica DMR-HC upright microscope. ImageJ (NIH, Bethesda, MD) was used to identify blood vessel areas, defined by the presence of vWF, and measure the fluorescence of the area and intensity of oxLDL within the vessel walls. For each vessel visualized, the intensity of oxLDL was calculated for the area of the vessel and corrected for background intensity. The total fluorescence for each muscle biopsy was calculated by dividing the sum of the intensities of the individual vessels by the sum of the area of the vessels. Data was analyzed using t-tests and Pearson correlation.

Results: Children with untreated JDM demonstrated higher fluorescence of oxLDL in the walls of muscle vasculature compared to healthy children (p=0.03, Figure 1). Secondary analysis revealed significantly higher oxLDL fluorescence in muscle biopsies of patients with the TNF-a-308 G allele compared to biopsies of patients with the A allele (p=0.04, Figure 2). Within the JDM cohort, there was a trend towards increased oxLDL fluorescence with longer duration of untreated disease at time of MBx. There was no significant correlation found between oxLDL fluorescence and markers of disease activity including disease activity (DAS) scores, nailfold capillary end row loops, muscle enzymes, serum vWF antigen, or neopterin.

Conclusion: Increased deposition of oxLDL within blood vessels of children with JDM supports the concern that these children are at increased risk for premature atherosclerosis. Additional longitudinal studies are needed to better understand the long term impact on morbidity and mortality.

Figure 1: Fluorescence of oxLDL (intensity/area) in the walls of muscle vasculature is increased in JDM muscle biopsies compared to healthy controls (p=0.03). The mean value is indicated by the line, and the standard deviation is indicated by the whiskers. JDM patients, n=20, and healthy controls, n=5.

Figure 2: Fluorescence of oxLDL (intensity/area) in the walls of muscle vasculature is increased in subjects with the GG polymorphism at the TNFa_308 gene locus compared to subjects with the GA polymorphism (p=0.04).


Disclosures: J. Spitznagle, None; A. Kacha-Ochana, None; J. Cook-Mills, None; A. Khojah, None; G. Morgan, None; L. Pachman, None.

To cite this abstract in AMA style:

Spitznagle J, Kacha-Ochana A, Cook-Mills J, Khojah A, Morgan G, Pachman L. Vascular Deposition of Oxidized LDL Is Increased in Children with Untreated Juvenile Dermatomyositis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/vascular-deposition-of-oxidized-ldl-is-increased-in-children-with-untreated-juvenile-dermatomyositis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/vascular-deposition-of-oxidized-ldl-is-increased-in-children-with-untreated-juvenile-dermatomyositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology